Hyperglycemia as a prognostic factor of mortality in patients with SARS-CoV-2

• Autor: Camacho-Saavedra, Luis Arturo
• Formato: artículo
• Fecha de Publicación: 2020
• Institución: Sociedad Peruana de Medicina Interna
• Repositorio: Revista SPMI - Revista de la Sociedad Peruana de Medicina Interna
• Lenguaje: español
• OAI Identifier: oai:ojs.medicinainterna.net.pe:article/562
• Enlace del recurso: http://revistamedicinainterna.net/index.php/spmi/article/view/562
• Nivel de acceso: acceso abierto
• Materia: Hyperglycemia; severe acute respiratory syndrome; viral pneumonia; viral; coronavirus infections; COVID-19; Hiperglucemia; síndrome respiratorio agudo grave; neumonía viral, viral; infecciones por coronavirus

 A research was made on whether hyperglycemia is a predictor of mortality in patients infected with SARS-Cov 2. Articles were searched in the PubMed and Google Scholar databases until July 30, 2020. The keywords were used: “Hyperglycemia”, “Serious Acute Respiratory Syndrome”, “Viral Pneumonia”, “Virosis”, “Coronavirus Infections”, “incubation period”, “transmission”, “clinical characteristics”, “physiopathology”, “hyperglycemia”, with the interposition of the Boolean operator” and “”. In addition, we access the scientific literature and recommendations currently available on WHO websites and the U.S. Centers for Disease Control and Prevention (CDC). Patients infected with SARS-CoV-2 and hyperglycemia (blood glucose >180 mg /dL) had higher mortality compared to patients with controlled blood glucose. Acute or chronic hyperglycemia and, moreover, when it  remains uncontrolled is associated with increased severity and mortality in patients infected with SARS-CoV-2.